Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)

And THIS is why we vaccinate

Anonymous
Posted by Anonymous
  • 35 Replies
Posted by Anonymous on Feb. 14, 2014 at 6:17 PM
Add your quick reply below:
You must be a member to reply to this post.
Replies (1-10):
Anonymous
by Anonymous 1 - Original Poster on Feb. 14, 2014 at 6:19 PM

BUMP!

Anonymous
by Anonymous 2 on Feb. 14, 2014 at 6:20 PM
3 moms liked this
There was an 'outbreak' of measles in my area, and all who contract edit were fully vaxed. Also, it's measles... So what?
Anonymous
by Anonymous 1 - Original Poster on Feb. 14, 2014 at 6:22 PM

Well, my daughter haas asthma and considering that measles is respiratory virus, it would be quite serious for HER to get it. 

Anonymous
by Anonymous 3 on Feb. 14, 2014 at 6:24 PM
4 moms liked this

MORE fearmongering bullshit...

Anonymous
by Anonymous 3 on Feb. 14, 2014 at 6:25 PM

if she's vaxed you should not have any worries

Quoting Anonymous:

Well, my daughter haas asthma and considering that measles is respiratory virus, it would be quite serious for HER to get it. 


Anonymous
by Anonymous 1 - Original Poster on Feb. 14, 2014 at 6:26 PM

She is and I don't, but that's the answer to "it's measles....so what?"

Quoting Anonymous:

if she's vaxed you should not have any worries

Quoting Anonymous:

Well, my daughter haas asthma and considering that measles is respiratory virus, it would be quite serious for HER to get it. 



Anonymous
by Anonymous 3 on Feb. 14, 2014 at 6:26 PM
Pediatrics. 2013 Nov;132(5):e1126-33. doi: 10.1542/peds.2012-3975. Epub 2013 Oct 21.

Measles in children vaccinated with 2 doses of MMR.

Abstract

OBJECTIVE:

A previous measles outbreak investigation in a high school in Quebec, Canada identified 2-dose vaccine effectiveness of 94%. The risk of measles in 2-dose recipients was significantly higher (2-4 times) when measles vaccine was first administered at 12 versus β‰₯ 15 months of age, with no significant effect of the age at second dose. Generalizability of this association was also assessed in the expanded provincial data set of notified cases.

METHODS:

This matched case-control study included only 2-dose recipients. All confirmed (laboratory or epidemiologically linked) cases in patients aged 5 to 17 years were included. Each case was matched to 5 controls.

RESULTS:

A total of 102 cases and 510 controls were included; 89% of cases were in patients 13 to 17 years old. When the first dose was administered at 12 to 13 months compared with β‰₯ 15 months of age, the risk of measles in participants outside the outbreak school was 6 times higher (95% confidence interval, 1.33-29.3) and was 5.2 times higher (95% confidence interval, 1.91-14.3) in the pooled estimate (participants from the outbreak school + outside that school).

CONCLUSIONS:

A significantly greater risk of measles among 2-dose recipients whose first dose was given at 12 to 13 months rather than β‰₯ 15 months of age is confirmed in the larger Quebec data set. The mechanism remains unknown, but vaccine failures in 2-dose recipients could have substantial implications for measles elimination efforts through 2-dose vaccination. The optimal age at first dose may warrant additional evaluation.

KEYWORDS:

measles, vaccine effectiveness

PMID:
 
24144708
 
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

Anonymous
by Anonymous 1 - Original Poster on Feb. 14, 2014 at 6:26 PM

LOL...okay. 

Quoting Anonymous:

MORE fearmongering bullshit...


Anonymous
by Anonymous 3 on Feb. 14, 2014 at 6:27 PM
Anonymous
by Anonymous 3 on Feb. 14, 2014 at 6:27 PM

Vaccine-associated "wild-type" measles.

Source

Department of Dermatology, Rush Presbyterian St. Lukes Medical Center, Chicago, Illinois 60612, USA. kelleliermann@yahoo.com

Abstract

Measles is the most contagious of the childhood exanthems and is the leading cause of vaccine-preventable deaths in children, mostly in developing countries. The prodromal stage, consisting of high fever and the triad of cough, coryza, and conjunctivitis, is followed by a caudal progressing rash over a period of 2 to 3 days. With a worldwide vaccination program in place, mortality and morbidity have decreased substantially. Receipt of the live attenuated vaccine generally causes no or only mild side effects such as a low-grade fever and a subtle rash. We report a 1-year-old boy who, 10 days after vaccination, developed vaccine measles which was clinically indistinguishable from the natural disease. Vaccine virus was detected by polymerase chain reaction in the patient's nasopharyngeal secretions.

PMID:
 
15804301
 
[PubMed - indexed for MEDLINE]
Add your quick reply below:
You must be a member to reply to this post.
Join the Meeting Place for Moms!
Talk to other moms, share advice, and have fun!

(minimum 6 characters)